Abstract:Abstract Background Dengue and Chikungunya are Aedes-borne diseases that are predominantly prevalent in tropical and subtropical regions, affecting public health globally. Dengue is caused by multiple antigenically different Dengue virus (DENV) serotypes (DENV-1 to DENV-4) in the Flaviviridae family and Chikungunya (CHIKV) in the Togaviridae family. Both viral diseases can produce similar clinical manifestations, especially in the early stages of infection which poses a significant challenge for timely diagnosis and improper disease management. Currently in India, diagnosis of Dengue and Chikungunya relies on ELISA-based tests, which often lead to false negatives and under estimation of the actual disease burden. The city of Bengaluru, in the state of Karnataka, in Southern India, witnesses spike in Dengue infection, and hence it is important to diagnose these arboviral infections early as well as accurately, to estimate the disease burden for precise epidemiological assessments. Methods A multiplex, quantitative, real-time PCR assay, DENCHIK was developed that can detect and differentiate between all four DENV serotypes and CHIKV infections simultaneously. Using DENCHIK assay, a total of 903 sera samples from suspected febrile patients were screened. The blood samples were collected across 161 public health centers, maternity homes and referral hospitals, in urban Bengaluru, between July 2022 - December 2022. The sensitivity and specificity of DENCHIK assay was compared with ELISA (NS1 antigen and Immunoglobulin M (IgM) antibodies) and two commercially available q RT-PCR assays for DENV and CHIKV. Findings Using DENCHIK assay, out of 903 samples, 36% infections were DENV, 17% CHIKV infections and 8% were coinfections with DENV-CHIKV. In contrast, ELISA detected 29.90% of DENV and 22.92% of CHIKV infections. We observed 9% prevalence of DENV infections using NS1 ELISA as compared to 24% as detected by IgM ELISA. DENV-1 was the predominant serotype followed by DENV-2, DENV-3 and DENV-4. There was an increase in the prevalence of DENV and CHIKV infections from June 2022 to September 2022, coinciding with the monsoon season. However, there was no significant difference observed in the prevalence of DENV and CHIKV infections across genders and age groups. The sensitivity and specificity of DENCHIK assay in DENV detection as compared to NS1 ELISA assay was observed to be 62.82% and 66.45%, respectively. In comparison to commercially available q RT-PCR assays for DENV detection, DENCHIK assay exhibited 99% and 98% sensitivity and specificity, respectively. Similarly, in case of CHIKV 26% sensitivity, 86% specificity and 98% sensitivity and specificity were observed, as compared to the IgM ELISA and commercial RT-PCR assays, respectively. Conclusion DENCHIK assay successfully enabled, simultaneous amplification of all four DENV serotypes and Chikungunya, in a single tube from clinical samples with high sensitivity and specificity. DENCHIK assay detected 7.6% of additional Dengue infections and 6.65% less of Chikungunya infections in clinical samples, as compared to detection by ELISA. As, compared to ELISA, DENCHIK demonstrates early and accurate detection of DENV and CHIKV with higher sensitivity and specificity as early as day one of symptom onset post infection. DENCHIK aids in estimating the exact prevalence of DENV and CHIKV infections, that are often misdiagnosed or overestimated, respectively, using routine serological assays such as ELISA. Molecular surveillance using targeted diagnostic assays such as DENCHIK could be used to determine the prevalence of multiple DENV serotypes, CHIKV and DENV-CHIKV Co-infections from clinical samples. The findings from the study shall be useful to inform and aid the public health authorities, to contain and curb the rapid spread of these diseases in the community.

Evaluation of assays for nucleic acid testing for the prevention of chikungunya and dengue virus transmission by blood transfusion

Preliminary survey of three mosquito-borne viruses using a self-established multiplex RT-qPCR assay in Chinese blood donors

Diagnostic Accuracy of Five Molecular Assays for the Detection of Dengue Virus

A prospective, multi‐centric study on the prevalence of dengue, zika and chikungunya in asymptomatic blood donors from different geographical regions of Brazil

Development of Multiplex Molecular Assays for Simultaneous Detection of Dengue Serotypes and Chikungunya Virus for Arbovirus Surveillance

Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2

Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum

Haemovigilance survey and screening strategy for arthropod‐borne viruses in blood donors from Argentina

Utilization of novel molecular multiplex methods for the detection and, epidemiological surveillance of dengue virus serotypes and chikungunya virus in Burkina Faso, West Africa

Direct Dengue Virus Genome Sequencing from Antigen NS1 Rapid Diagnostic Tests: A Proof-of-Concept with the Standard Q Dengue Duo Assay

Simultaneous detection and quantitation of Chikungunya, dengue and West Nile viruses by multiplex RT-PCR assays and dengue virus typing using high resolution melting

Development of a cost-effective multiplex quantitative RT-PCR assay for early detection and surveillance of Dengue, Chikungunya, and co-infections from clinical samples in low-resource settings

Rapid and sensitive detection of chikungunya virus using one-tube, reverse transcription, semi-nested multi-enzyme isothermal rapid amplification, and lateral flow dipstick assays

Performance evaluation of TaqMan™ Arbovirus Triplex Kit (ZIKV/DENV/CHIKV) for detection and differentiation of Dengue and Chikungunya viral RNA in serum samples of symptomatic patients

Evaluation of an immunochromatography rapid diagnosis kit for detection of chikungunya virus antigen in India, a dengue-endemic country

Promising application of monoclonal antibody against chikungunya virus E1-antigen across genotypes in immunochromatographic rapid diagnostic tests

Distribution of Dengue Virus Types 1 and 4 in Blood Components from Infected Blood Donors from Puerto Rico

Evaluation of Multiple RNA Extraction Protocols for Chikungunya Virus Screening in Aedes aegypti Mosquitoes

Analysis of a Routinely Used Commercial Anti-Chikungunya IgM ELISA Reveals Cross-Reactivities with Dengue in Brazil: A New Challenge for Differential Diagnosis?

Quantitative detection of chikungunya, Zika, and dengue viruses by one-step real-time PCR in different cell substrates

External quality assessment studies for laboratory performance of molecular and serological diagnosis of Chikungunya virus infection